XP's Q1 revenues reflect varying performance by end-market: encouraging growth from industrial, healthcare and technology customers was offset by the expected decline in demand from the semiconductor sector. Order intake was higher on a year-on-year and quarter-on-quarter basis, resulting in a book-to-bill of 1.16x for the quarter. With management's full-year expectations unchanged, we maintain our forecasts.Den vollständigen Artikel lesen ...
© 2019 Edison Investment Research